Remdesivir
-
Need to break Covid transmission chain by imposing lockdown: Uddhav in task force meet
India | Apr 12, 2021, 12:15 AM ISTMaharashtra Chief Minister Uddhav Thackeray on Sunday discussed setting up of oxygen generation plants, upgrading the number of beds and other medical facilities, besides availability of Remdesivir injections in a meeting held with members of the state COVID-19 task force. The Chief Minister in the task force meeting once again talked about imposing lockdown saying it will break Covid transmission rate.
-
India bans export of remdesivir till COVID situation improves
India | Apr 12, 2021, 12:11 AM ISTIn view of increased demand for remdesivir due to a surge in COVID-19 cases, the Centre on Sunday said the export of the antiviral injection and its Active Pharmaceutical Ingredients (API) has been banned till the situation improves.
-
Remdesivir shortage in Nagpur; Gadkari dials Sun Pharma chief
India | Apr 11, 2021, 11:49 AM ISTUnion minister Nitin Gadkari has called up Sun Pharma's chief to arrange for 10,000 injections of Remdesivir in Nagpur in view of a shortage of the medicine here in Maharashtra.
-
People gather outside Indore medical store in view of alleged shortage of Remdesivir
News | Apr 10, 2021, 03:02 PM ISTPeople gathered in front of a medical store in MP's Indore in view of alleged shortage of Remdesivir. A local said, "I'm standing in queue since y'day. We did 'chakka jam' today.
-
Remdesivir may be highly effective against coronavirus, case study finds
Science | Dec 14, 2020, 05:56 PM ISTRemdesivir may be a highly effective antiviral against SARS-CoV-2, the virus that causes COVID-19, according to a new single-patient study that contradicts previous research which found the drug had no impact on death rates from the disease.
-
New study shows baricitinib with remdesivir promising for treating COVID-19
Science | Dec 12, 2020, 07:37 PM ISTThe combination of baricitinib, an anti-inflammatory drug, and remdesivir, an antiviral, reduced time to recovery for people hospitalized with COVID-19, according to clinical trial results published Friday in the New England Journal of Medicine.
-
COVID Fight: Delhi health minister thanks Shah Rukh Khan for donating Remdesivir injections
Celebrities | Dec 10, 2020, 05:56 PM ISTDelhi Health Minister Satyendar Jain thanked Bollywood actor Shah Rukh Khan for donating 500 Remdesivir injections.
-
How effective is remdesivir against COVID-19? Clash of opinions among health experts
World | Nov 20, 2020, 09:09 PM ISTWorld Health Organization guidelines panel advised against using the antiviral remdesivir for hospitalized patients, saying there’s no evidence it improves survival or avoids the need for breathing machines.
-
SC seeks Centre's reply on plea alleging no approval for Remdesivir, Favipiravir to treat COVID-19
India | Oct 29, 2020, 01:51 PM ISTThe Supreme Court Thursday sought response from the Centre on a plea alleging that two medicines Remdesivir and Favipiravir, are being used for treatment of COVID-19 without approval.
-
Antiviral Remdesivir: US approves first drug to treat COVID-19
World | Oct 23, 2020, 08:50 AM ISTThe drug, which California-based Gilead Sciences Inc. is calling Veklury, cut the time to recovery by five days — from 15 days to 10 on average — in a large study led by the U.S. National Institutes of Health.
-
Remdesivir did not cut hospital stay or mortality in COVID patients: WHO
World | Oct 16, 2020, 08:41 AM ISTGilead Sciences Inc's remdesivir had little or no effect on COVID-19 patients' length of hospital stay or chances of survival, a clinical trial by the World Health Organization (WHO) has found. The antiviral medication was among the first to be used as a treatment for COVID-19.
-
Remdesivir, coronavirus treatment drug, batch withdrawn due to inferior quality: Maharashtra govt
India | Sep 23, 2020, 05:55 PM ISTA batch of Remdesivir for treatment of COVID-19 patients has been withdrawn in view of 'sub-standard quality' of the medicine, Maharashtra Health Minister Rajesh Tope said on Wednesday.
-
Favipiravir tablet, Remdesivir now available in Odisha market for COVID patient's treatment
India | Sep 12, 2020, 10:06 PM ISTAmid surge of coronavirus cases in Odisha, the state government has allowed the sale of Favipiravir tablet and Remdesivir injectable formulation in stores for the treatment of coronavirus patients on Saturday.
-
Dr. Reddy's launches —Redyx— COVID-19 drug Remdesivir in India
Business | Sep 09, 2020, 11:31 AM ISTDr. Reddys Laboratories Ltd on Wednesday announced the launch of Remdesivir, meant for treatment of COVID-19 patients, under a brand name 'Redyx' in India.
-
Jubilant Life Sciences launches generic version of remdesivir for COVID-19 treatment
Business | Aug 03, 2020, 09:42 PM ISTThe company will make the drug available to over 1,000 hospitals providing COVID-19 treatment, Jubilant Life Sciences said in a statement.
-
Health ministry asks DCGI to ensure equitable distribution of Remdesivir, Tocilizumab drugs
India | Jul 29, 2020, 09:07 PM ISTThe Union health ministry has asked the Drugs Controller General of India to ensure equitable distribution of Remdesivir and Tocilizumab drugs, which have been included as "investigational therapies" in the national treatment protocols for COVID-19, across the country.
-
Canada authorises remdesivir to treat patients of severe coronavirus
World | Jul 29, 2020, 08:59 AM ISTCanada has announced its authorisation for using the drug remdesivir for treating patients suffering severe symptoms of Covid-19 who have pneumonia and require extra oxygen to help them breathe.
-
FDA busts Remdesivir black marketing nexus in Mumbai
News | Jul 23, 2020, 08:26 AM ISTThe police on Wednesday arrested several persons in connection with black marketing of Remdesivir and Tocilizumab injections, used in Covid-19 treatment.
-
Jubilant Life Science gets nod for emergency use of Remdesivir
India | Jul 20, 2020, 09:45 PM ISTNoida-headquartered Jubilant Life Science has reportedly received permission to manufacture Remdesivir for emergency use with same conditions as given to other companies like Hetero, Cipla and Mylan.
-
Mylan launches generic version of Remdesivir in India for COVID-19 patients
Business | Jul 20, 2020, 02:46 PM ISTPharma major Mylan on Monday said it has commercially launched the generic version of Remdesivir drug under the brand name 'Desrem' in India for treatment of coronavirus patients.